Evidence map›Paper›PMID 39661601›Full record

ArticlePloS one2024

Evaluating meta-analysis as a replication success measure.

Jasmine Muradchanian, Rink Hoekstra, Henk Kiers, Don van Ravenzwaaij

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The assessment of replicability using the sum ofRoyal Society open science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jasmine MuradchanianBehavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.ORCID 0000-0002-2914-9197
Rink HoekstraBehavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.
Henk KiersBehavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.
Don van RavenzwaaijBehavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.ORCID 0000-0002-5030-4091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe importance of replication in the social and behavioural sciences has been emphasized for decades. Various frequentist and Bayesian approaches have been proposed to qualify a replication study as successful or unsuccessful. One of them is meta-analysis. The focus of the present study is on the way meta-analysis functions as a replication success metric. To investigate this, original and replication studies that are part of two large-scale replication projects were used. For each original study, the probability of replication success was calculated using meta-analysis under different assumptions of the underlying population effect when replication results were unknown. The accuracy of the predicted overall replication success was evaluated once replication results became available using adjusted Brier scores.

resultsOur results showed that meta-analysis performed poorly when used as a replication success metric. In many cases, quantifying replication success using meta-analysis resulted in the conclusion where the replication was deemed a success regardless of the results of the replication study. DISCUSSION: We conclude that when using meta-analysis as a replication success metric, it has a relatively high probability of finding evidence in favour of a non-zero population effect even when it is zero. This behaviour largely results from the significance of the original study. Furthermore, we argue that there are fundamental reasons against using meta-analysis as a metric for replication success.

Indexed as

Meta-Analysis as TopicBayes TheoremHumansReproducibility of Results

Identifiers

PMID39661601
PMCPMC11633967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.